Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
about
Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?Urologic cancer in TaiwanRobot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience.Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissectionGenome-wide mutational signatures of aristolochic acid and its application as a screening tool.Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.Safety surveillance of traditional Chinese medicine: current and futureUreteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinomaAssociation of dialysis with the risks of cancers.Mutation signatures implicate aristolochic acid in bladder cancer developmentPreoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity.Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma.Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy.Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review.Analysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China.Nephroureterectomy increase 5 year survival in patients on dialysis with upper urinary tract urothelial carcinoma.Genomics traces carcinogen fingerprints.Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.Cancer Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 5 of 5.Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan.Dialysis Increases the Risk of Bladder Recurrence in Patients with Upper Tract Urothelial Cancer: A Population-Based Study.Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma.Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma.Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.Update of aristolochic acid nephropathy in Korea
P2860
Q28067471-5AACD325-0BD0-4500-811E-4DF128033454Q28079868-26C39307-96BC-427B-9E30-A05841B2F132Q33987616-6D6E276F-8430-4B05-8E96-8EC6C8312899Q34080219-77794E9D-8494-4BA0-B39C-754E9D9528B9Q34128720-9FC9747A-B4B8-4AC3-AF70-173F09F45665Q34362611-29CF5942-49BC-4C8C-915E-0CE487DD6A2CQ34362617-D98BE55F-2AEC-4268-9D2D-8F8B8A931DD4Q35142633-4BEE6B13-2B57-492B-8223-E7C20C963A59Q35271198-23BDB496-49A4-4DFB-82D2-81B3CE1B904BQ35392850-CB626589-4BBB-420D-A7BC-74416B4B5B5AQ35646186-B92344F5-3BA5-4E09-BBFF-07570A16EBDBQ35940860-2D056C54-ADEF-4B72-930F-FB5103F2B238Q36157755-AE06FA6C-8C71-48F6-B9C6-2F2C596E0659Q37564385-A6B5CC91-7967-4B1B-BFB8-BC158117DCF8Q37641663-ACA6AFE3-AD45-4513-88FF-A21647D4E07EQ38218441-76BF0A49-3E63-4251-BC5D-532F87556A39Q41649479-903FCADE-7F11-41F3-A61A-1F8808B67717Q43197349-9EDC1BA2-80DF-4402-9596-8FE09B704875Q45157753-47134CA3-328A-487A-9F96-BB72D03B31D8Q47225514-07C3FA27-DDC3-4F6D-9593-22B1315B2561Q47748877-AEC04213-FECA-4733-8543-F1A1398117C3Q47754870-7F2143C6-4B07-41A6-BCDF-694DF8C16AB3Q50057691-4B674822-1081-4D7D-B6F6-7581A6CF6B3EQ51058859-4D307ECC-C668-4FAD-B831-49D295C5A435Q52646970-176B31E1-9DDB-4F38-B9F7-AE08B341C82BQ52948462-46658FED-7FA8-409D-A597-0FDB785D2FBEQ53667483-BA8C9C46-F108-4003-A73A-8BE410C6984BQ57213397-6AFA3ED7-6B07-4410-8CEB-5B0E093716B9
P2860
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Aristolochic acid-induced uppe ...... characteristics and outcomes.
@en
Aristolochic acid-induced uppe ...... characteristics and outcomes.
@nl
type
label
Aristolochic acid-induced uppe ...... characteristics and outcomes.
@en
Aristolochic acid-induced uppe ...... characteristics and outcomes.
@nl
prefLabel
Aristolochic acid-induced uppe ...... characteristics and outcomes.
@en
Aristolochic acid-induced uppe ...... characteristics and outcomes.
@nl
P2093
P2860
P50
P356
P1476
Aristolochic acid-induced uppe ...... l characteristics and outcomes
@en
P2093
Arthur P Grollman
Chao-Yuan Huang
Kathleen G Dickman
Kuo-How Huang
Masaaki Moriya
Yuan-Ju Lee
P2860
P356
10.1002/IJC.28013
P577
2013-02-12T00:00:00Z